Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation in Adults Using Fludarabine, Carmustine, Melphalan, and Antithymocyte Globulin: Outcomes Depend on Disease Risk Index but Not Age, Comorbidity Score, Donor Type, or Human Leukocyte Antigen Mismatch-Reference-Cited by-同舟云学术

Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation in Adults Using Fludarabine, Carmustine, Melphalan, and Antithymocyte Globulin: Outcomes Depend on Disease Risk Index but Not Age, Comorbidity Score, Donor Type, or Human Leukocyte Antigen Mismatch

Published:2013-08 Issue:8 Volume:19 Page:1167-1174
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Slack James L.,Dueck Amylou C.,Fauble Veena D.,Sproat Lisa O.,Reeder Craig B.,Noel Pierre,Khera Nandita,Betcher Jeffery A.,Klein Jared L.,Leis Jose F.,Adams Roberta H.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference24 articles.

1. Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies;Porter;Amer Soc Hematol ('Education Program),2011

2. Reduced-intensity conditioning in allogeneic stem cell transplantation for hematological malignancies: a historical perspective;Cremer;Onkologie,2011

3. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS;De Lima;Blood,2004

4. Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies;Marks;Blood,2008

5. A disease risk index for patients undergoing allogeneic stem cell transplantation;Armand;Blood,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease;Expert Review of Hematology;2019-04-19

2. Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome;Bone Marrow Transplantation;2018-09-26

3. Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis;Bone Marrow Transplantation;2018-05-24

4. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting;Medical Oncology;2018-04-25

5. Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation;Biology of Blood and Marrow Transplantation;2018-02